glp-1 drug exposure pharmaceutical companies 2025 Receptor Agonist Market Valued at USD 62.86 Billion in 2025, Set to Grow at 17.5% CAGR Through 2034 GLP-1 Trends: Access & Shortages,

Prescribing Information: Accutane

Adequate hydration and nutrition : Ensure sufficient fluid intake, particularly if experiencing gastrointestinal side effects

Potential drug interactions also warrant attention, as probiotics may alter the pharmacokinetics or efficacy of immunosuppressive therapies, thereby increasing infection risk or compromising therapeutic outcomes, posing particular concerns for patients undergoing chemotherapy, organ transplant recipients, and individuals with HIV/AIDS

Diabetes Technol Ther

not necessarily related to need in any way

Prospective Studies Collaboration, Whitlock G, Lewington S, et al